Publications & Works

Publication Network
Articles 45
All (45)
SCI-E, SSCI, AHCI (37)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (4)
Scopus (41)
TRDizin (8)
Other Publications (1)

1. New 2,3-dihydrothiazole derivatives against Helicobacter pylori: Synthesis, biological evaluation and molecular docking studies

TOK F., Keskin Z., BALTAŞ N., RAYAMAN E., Atici C. E., Turgut-Solak Z. D., et al.
JOURNAL OF MOLECULAR STRUCTURE , vol.1361, 2026 (SCI-Expanded, Scopus)

2. Therapeutic potential of sulfonate-based hydrazide hydrazones in neurodegenerative diseases: SAR insights and molecular modeling studies.

Aktar B. S. K., Karaküçük-İyidoğan A., Yılmaz G., Oruç-Emre E. E., Sıcak Y., Bakırdöven A., et al.
Future medicinal chemistry , pp.1-19, 2026 (SCI-Expanded, Scopus)

3. Piperidine-Based Hydrazones and Their Pt(II)/Pd(II) Complexes: Synthesis, Structural Characterization, In Vitro Anticancer Evaluation, and In Silico Studies

DOĞAN M. O., Oruç-Emre E. E., Alyamaç İ. T., Taşdemir D., Turgut Solak Z. D., TATAR YILMAZ G., et al.
Drug Development Research , vol.87, no.2, 2026 (SCI-Expanded, Scopus)

4. Synthesis, Biological Evaluation and Molecular Docking Studies of New 4-(Cyanomethyl)-N'-Substituted Benzohydrazide Derivatives as Anti-Alzheimer Agents

TOK F., BALTAŞ N., Abas B. İ., Kozan B., Kaya S., TATAR YILMAZ G., et al.
Drug Development Research , vol.86, no.7, 2025 (SCI-Expanded, Scopus)

5. Novel Pyrrolidine-Based Pyrazolines as α-Glucosidase Inhibitors: Microwave-Assisted Synthesis, Antidiabetic Activity, In Silico ADMET Prediction, Molecular Docking, and Molecular Dynamics Simulations

Kurşun Aktar B. S., Sıcak Y., Bakırdöven A., TATAR YILMAZ G., Kaya S., Karaküçük-İyidoğan A., et al.
ACS Omega , vol.10, no.39, pp.45450-45464, 2025 (SCI-Expanded, Scopus)

6. Design, Synthesis, Antidiabetic Activity and In Silico Studies of New Hydrazone Derivatives Derived from Acetohexamide

Kursun Aktar B. S., Sicak Y., Oruc-Emre E. E., Kilic R., Saglam E., Tasdemir D., et al.
ACS OMEGA , vol.10, no.38, pp.43916-43931, 2025 (SCI-Expanded, Scopus) Sustainable Development

7. In Silico Investigation of Antimicrobial Agents Targeting Enterococcus Faecalis: Using Molecular Docking, Molecular Dynamics Simulations, and MM-GBSA Analysis

Berberoglu I. N., TATAR YILMAZ G., TÜZÜNER T.
CHEMISTRYSELECT , vol.10, no.37, 2025 (SCI-Expanded, Scopus) Sustainable Development

8. Novel thiazole derivatives as effective anti-cancer agents against human osteosarcoma cell line (SaOS-2): Microwave-assisted one-pot three-component synthesis, in vitro anti-cancer studies, and in silico investigations

Mermer A., Tahmasebifar A., Al-Hussain S. A., Yılmaz G. T., Turgut Z. D., Mushtaq A., et al.
PLOS ONE , vol.20, no.8 August, 2025 (SCI-Expanded, Scopus) Creative Commons License

9. Evaluation of synthesized methoxy chalcones for therapeutic potential through in vitro and in silico methods

Erik Z., ERİK İ., YALÇIN C. Ö., ŞENER S. Ö., ALPAY KARAOĞLU Ş., TATAR YILMAZ G., et al.
Journal of Research in Pharmacy , vol.29, no.4, pp.1693-1711, 2025 (ESCI, Scopus, TRDizin)

10. Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-β-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19

Celik G., ALPAY KARAOĞLU Ş., SUYABATMAZ Ş., BOZDEVECİ A., TATAR YILMAZ G., YAYLI N., et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.298, 2025 (SCI-Expanded, Scopus)

11. Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening

Kurşun Aktar B. S., Sıcak Y., Bakırdöven A., Yılmaz G. T., Yılmaz Ö., Karaküçük-İyidoğan A., et al.
ACS Omega , vol.10, no.9, pp.9368-9380, 2025 (SCI-Expanded, Scopus)

12. Exploring Inhibition Mechanisms in Wildtype and T315I BCR-ABL1: An In Silico Approach Integrating Virtual Screening, MD Simulations, and MM-GBSA Analysis

BALTA Ö., YILMAZ E., TATAR YILMAZ G.
JOURNAL OF COMPUTATIONAL CHEMISTRY , vol.46, no.1, 2025 (SCI-Expanded, Scopus)

13. Exploring 2-Pyrazoline derivatives as potent antidiabetic agents and cholinesterase inhibitors: Their synthesis and molecular docking studies

Uğraş Z., TOK F., Çakir C., Tuna K., TATAR YILMAZ G., Mutlu D., et al.
JOURNAL OF MOLECULAR STRUCTURE , vol.1315, 2024 (SCI-Expanded, Scopus) Sustainable Development

14. Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs)

Karaküçük-İyidoğan A., Başaran E., TATAR YILMAZ G., Oruç-Emre E. E.
BIOORGANIC CHEMISTRY , vol.151, 2024 (SCI-Expanded, Scopus) Sustainable Development

15. Design, synthesis, molecular modeling, in vitro evaluation of novel piperidine-containing hydrazone derivatives as cholinesterase inhibitors

TOK F., Baltas N., Abas B. I., Tatar Yilmaz G., Kaya S., Kocyigit-Kaymakcioglu B., et al.
DRUG DEVELOPMENT RESEARCH , vol.85, no.5, 2024 (SCI-Expanded, Scopus)

16. Discovery of New Dual-Target Agents Against PPAR-γ and α-Glucosidase Enzymes with Molecular Modeling Methods: Molecular Docking, Molecular Dynamic Simulations, and MM/PBSA Analysis

Kaya S., TATAR YILMAZ G., Aktar B. S. K., Emre E. E. O.
Protein Journal , vol.43, no.3, pp.577-591, 2024 (SCI-Expanded, Scopus)

17. Synthesis, Antimicrobial Activities, and Molecular Modeling Studies of Agents for the Sortase A Enzyme

Tatar Yılmaz G., Yayli N., Tüzüner T., Bozdal G., Salmanli M., Renda G., et al.
CHEMISTRY & BIODIVERSITY , vol.21, no.5, 2024 (SCI-Expanded, Scopus) Sustainable Development

18. Synthesis, Biological Investigation, and Molecular Docking of Novel Benzimidazole-Hydrazone Hybrids as Potential Anticancer Agent Candidates

Demirci S., Köprülü T. K., Mermer A., Yılmaz G. T.
ChemistrySelect , vol.9, no.9, 2024 (SCI-Expanded, Scopus)

19. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies

Kursun-Aktar B. S., Adem S., Tatar-Yilmaz G., Hameed Z. A. H., Oruc-Emre E. E.
JOURNAL OF MOLECULAR RECOGNITION , vol.36, 2023 (SCI-Expanded, Scopus)

20. Design, Synthesis, Pharmacological Activities, Structure-Activity Relationship, and In Silico Studies of Novel 5-Substituted-2-(morpholinoimino)-thiazolidin-4-ones

Sicak Y., Aktar B. S. K., TATAR YILMAZ G., Ozturk F. A., Ozturk M., Tok T. T., et al.
ACS OMEGA , vol.8, no.41, pp.38641-38657, 2023 (SCI-Expanded, Scopus)

21. Design, in Silico Studies and Biological Evaluation of New Chiral Thiourea and 1,3-Thiazolidine-4,5-dione Derivatives

Evyapan S., Oruç-Emre E. E., Sıcak Y., Karaküçük-İyidoğan A., Yılmaz G., Öztürk M.
CHEMISTRY & BIODIVERSITY , vol.20, no.8, 2023 (SCI-Expanded, Scopus)

22. Synthesis and evaluation of the antioxidant and anti-tyrosinase activities of thiazolyl hydrazone derivatives and their application in the anti-browning of fresh-cut potato

Djafarou S., Mermer A., Barut B., Tatar Yılmaz G., Khodja I. A., Boulebd H.
FOOD CHEMISTRY , vol.414, 2023 (SCI-Expanded, Scopus)

23. Design, Synthesis, Biological Activity and Molecular Docking Studies of New Imine-Chalcone Derivatives

Çelik G., Yılmaz G. T., BARUT B., YALÇIN C. Ö., YAYLI N.
PHARMACEUTICAL CHEMISTRY JOURNAL , vol.57, no.4, pp.550-558, 2023 (SCI-Expanded, Scopus)

24. Diş Hekimliğine Yönelik Antimikrobiyal Ajanların Geliştirilmesinde Bilgisayar Destekli İlaç Tasarımının Rolü

Berberoğlu İ. N., Tatar Yılmaz G., Tüzüner T.
Türkiye Klinikleri Diş Hekimliği Bilimleri Dergisi , vol.1, no.1, pp.41-44, 2023 (TRDizin)

25. In silico modeling of α-glucosidase, aldose reductase, and PPAR-γ with benzoyl/sulfonyl hydrazone derivatives using molecular docking, ADMET, and molecular dynamics simulations

YILMAZ G., AKTAR B. S. K., ORUÇ EMRE E. E.
JOURNAL OF RESEARCH IN PHARMACY , vol.27, no.4, pp.1567-1576, 2023 (ESCI, TRDizin)

26. Design, synthesis, and enzyme inhibition evaluation of some novel Mono- and Di-O-β-D-Glycopyranosyl Chalcone analogues with molecular docking studies

Celik G., TATAR YILMAZ G., Sahin H., BARUT B., YAYLI N.
TURKISH JOURNAL OF CHEMISTRY , vol.47, no.1, pp.171-184, 2023 (SCI-Expanded, Scopus, TRDizin)

27. Synthesis of novel thiosemicarbazone derivatives as antidiabetic agent with enzyme kinetic studies and antioxidant activity

TOK F., KÜÇÜKAL B., BALTAŞ N., TATAR YILMAZ G., KAYMAKÇIOĞLU B.
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS , vol.197, no.12, pp.1284-1294, 2022 (SCI-Expanded, Scopus)

28. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.

Tatar G., Salmanli M., Dogru Y., Tuzuner T.
Journal of biomolecular structure & dynamics , vol.40, no.17, pp.7656-7665, 2022 (SCI-Expanded, Scopus) Sustainable Development

29. Synthesis, Antioxidant and Some Enzyme Inhibition Activities of New Sulfonyl Hydrazones and their Molecular Docking Simulations

Aktar B. S. K., Sicak Y., TATAR YILMAZ G., Oruc-Emre E. E.
PHARMACEUTICAL CHEMISTRY JOURNAL , vol.56, no.4, pp.559-569, 2022 (SCI-Expanded, Scopus)

30. Molecular docking, synthesis and biological evaluation (enzyme inhibition, antimicrobial and antioxidant) of methoxy benzoin/benzil/stilbenoid derivatives

Yaylı N., Kahriman N., Bozdal G., Serdaroğlu V., Aliyazıcıoğlu R., Sellitepe H. E., et al.
ORGANIC COMMUNICATIONS , vol.15, no.2, pp.129-147, 2022 (ESCI, Scopus, TRDizin) Creative Commons License

31. Synthesis, Biological Evaluation and in Silico Studies of New Pyrazoline Derivatives Bearing Benzo[d]thiazol-2(3H)-one Moiety as Potential Urease Inhibitors

TOK F., BALTAŞ N., TATAR YILMAZ G., KAYMAKÇIOĞLU B.
CHEMISTRY & BIODIVERSITY , vol.19, no.3, 2022 (SCI-Expanded, Scopus)

32. Synthesis of novel pancreatic lipase inhibitors: Biological investigation and in silico studies

Mermer A., Demirci S., TATAR G.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.40, no.2, pp.931-940, 2022 (SCI-Expanded, Scopus)

33. Synthesis of benzoyl hydrazones having 4-hydroxy-3,5-dimethoxy phenyl ring, their biological activities, and molecular modeling studies on enzyme inhibition activities

Kursun Aktar B. S., Sicak Y., TATAR YILMAZ G., Oruc-Emre E. E.
TURKISH JOURNAL OF CHEMISTRY , vol.46, pp.236-252, 2022 (SCI-Expanded, Scopus, TRDizin)

34. Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation

Tatar G., Taskin T.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.40, no.24, pp.13355-13365, 2022 (SCI-Expanded, Scopus) Sustainable Development

35. Bazı Kalkonların COVID-19 Tedavisine Yönelik SARS-CoV-2 Ana Proteaza Bağlanma Mekanizmasının Moleküler Kenetleme Yaklaşımı ile Aydınlatılması

Tatar Yılmaz G., Aktar B. S. K.
International journal of advances in engineering and pure sciences (Online) , vol.33, no.4, pp.660-669, 2021 (TRDizin) Sustainable Development

36. SARS-CoV-2 Ana Proteaz Enzimine Yönelik Antiviral Bileşiklerin Bilgisayar Destekli İlaç Tasarımı Yöntemleri ile Değerlendirilmesi

TATAR YILMAZ G., YILMAZ E.
European Journal of Science and Technology , no.32, pp.1043-1047, 2021 (TRDizin) Sustainable Development

37. Investigation of the antimicrobial activities of various antimicrobial agents on Streptococcus Mutans Sortase A through computer-aided drug design (CADD) approaches

SALMANLI M., Yilmaz G. T., TÜZÜNER T.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE , vol.212, 2021 (SCI-Expanded, Scopus) Sustainable Development

38. Synthesis, biological evaluation (antioxidant, antimicrobial, enzyme inhibition, and cytotoxic) and molecular docking study of hydroxy methoxy benzoin/benzil analogous

Yaylı N., Kılıç G., Kahriman N., Kanbolat Ş., Bozdeveci A., Alpay Karaoğlu Ş., et al.
BIOORGANIC CHEMISTRY , vol.115, 2021 (SCI-Expanded, Scopus) Sustainable Development

39. Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study

Guler H. İ., Tatar G., Yildiz O., Belduz A. O., Kolayli S.
ARCHIVES OF MICROBIOLOGY , vol.203, no.6, pp.3557-3564, 2021 (SCI-Expanded, Scopus) Sustainable Development

40. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo

Onder F. C., Kahraman N., Atici E. B., Cagir A., Kandemir H., Tatar G., et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE , vol.4, no.2, pp.926-940, 2021 (ESCI, Scopus) Sustainable Development

41. Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents

Tatar G., Ozyurt E., Turhan K.
BIOTECHNOLOGY PROGRESS , vol.37, no.2, 2021 (SCI-Expanded, Scopus)

42. Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: structure based docking, ADMET and molecular dynamics simulation

Secinti B. B., Tatar G., Tok T. T.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS , vol.37, no.9, pp.2457-2463, 2019 (SCI-Expanded, Scopus)

43. Synthesis, anticancer activity and ADMET studies of N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted)ureido/thioureido] benzenesulfonamide derivatives

KARAKUŞ S., TOK F., Tuerk S., ŞALVA E., Tatar G., Taskin-Tok T., et al.
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS , vol.193, no.8, pp.528-534, 2018 (SCI-Expanded, Scopus)

44. Structures and Functions of Coronavirus Proteins: Molecular Modeling of Viral Nucleoprotein

TAŞKIN TOK T., TATAR G.
International Journal of Virology Infectious Diseases , vol.2, no.1, 2017 (Peer-Reviewed Journal)

45. Clarification of Interaction Mechanism of Mouse Hepatitis Virus (MHV) N and nsp3 Protein with Homology Modeling and Protein-Protein Docking Analysis.

Tatar G., Tok T.
Current computer-aided drug design , 2016 (SCI-Expanded, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 24

1. Investigation of Novel Sulfonamide-Pyrazoline Hybrid Molecules with Potential Antidiabetic Activity Based on Molecular Modelling Against α-Glucosidase, Aldose Reductase and Dipeptidyl Peptidase 4 (DPP-4)

Çakır D. B., Tatar Yılmaz G., Kaymakçıoğlu B., İyidoğan A., Tok F., Taşdemir D., et al.
International Drug Chemistry, Antalya, Turkey, 6 - 09 February 2025, pp.35, (Summary Text)

2. Molecular Docking Analyses of Novel Chalcone-Based Compounds on the Inhibition of PTP1B Enzyme: Potential Inhibitor Candidates for Type 2 Diabetes Treatment

Turgut Z. D., Aktar B. S. K., Tatar Yılmaz G., Bulut Z., İyidoğan A., Taşdemir D., et al.
International Drug Chemistry, Antalya, Turkey, 6 - 09 February 2025, pp.64, (Summary Text)

3. Investigation of the Mechanism of Dual Inhibition of EGFR and HER2 Proteins Using Molecular Modeling Methods

Kılınç D., Buğday N., Yaşar Ş., Tatar Yılmaz G., Yaşar S., Çolak C.
International Drug Chemistry, Antalya, Turkey, 6 - 09 February 2025, pp.12, (Summary Text)

4. Oleuropein ve Türevi Bileşiklerin Streptococcus Mutans Enzimleri Üzerindeki İnhibitör Özelliklerinin İn-Siliko Olarak İncelenmesi

Berberoğlu İ. N., Tatar Yılmaz G., Renda G., Güdük Ö. F.
30. Uluslararası Türk Pedodonti Derneği Kongresi, Antalya, Turkey, 17 - 20 October 2024, pp.269-274, (Full Text)

5. Discovery of New Dual-Target Agents Against PPAR-γ and α-glucosidase Enzymes with Molecular Modeling Methods

Kaya S., Tatar Yılmaz G., Aktar B. S. K., Emre E. E.
4th Enzyme and Bioprocess Days (EBDays), Kars, Turkey, 7 - 09 September 2023, pp.64, (Full Text)

6. Exploring Promising Inhibitor Candidates for Estrogen Receptor Alpha Enzyme with Molecular Modelling Studies

Turgut Z. D., Tatar Yılmaz G.
4th Enzyme and Bioprocess Days (EBDays), Kars, Turkey, 7 - 09 September 2023, pp.63, (Full Text)

7. AKR1B1 Enzimine Yönelik Etkin Bileşiklerin Moleküler Kenetlenme Yöntemi ile İncelenmesi

Yaşar Ş., Tatar Yılmaz G., Çolak C.
14.Tıp Bilişimi Kongresi, İzmir, Turkey, 16 - 18 March 2023, pp.108-114, (Full Text)

8. Evaluation of The Effects of Different Formulations of Subunit Covid-19 Vaccine on Cytokine Levels in HepG2 Cells

Arca Çakır D., Yirün A., Aydın S., Varan G., Tatar Yılmaz G., Erkekoğlu Ü. P., et al.
11 INTERNATIONAL CONGRESS OF THE TURKISH SOCIETY OF TOXICOLOGY, Antalya, Turkey, 2 - 05 November 2022, pp.129, (Summary Text)

9. COVID-19 Tedavisine Yönelik İn Siliko İlaç Geliştirme Çalışmaları

Tatar Yılmaz G.
Uluslararası Ege Sağlık Alanları Sempozyumu, İzmir, Turkey, 18 - 19 December 2021, pp.120-121, (Summary Text) Sustainable Development

10. SARS-CoV-2 Spike, Main protease ve Nucleocapsid Proteinlerinin Molnupiravir ile Etkileşim Mekanizmasının Moleküler Kenetlenme Yöntemi ile İncelenmesi

Özyurt E., Tatar Yılmaz G., Turhan K.
13. TIP BİLİŞİMİ KONGRESİ, İstanbul, Turkey, 24 - 27 March 2021, pp.1-8, (Full Text) Sustainable Development

11. Evaluation Of Two Different Antibacterial Agents For Inhibition Of Streptococcus Mutans-Sortase A Enzyme Structure By Molecular Docking Method

SALMANLI M., TATAR G., TÜZÜNER T., YILMAZ N., BAYGIN Ö.
26.International Congress of Turkish Society of Pediatric Dentistry, 10 - 13 October 2019, pp.92-93, (Full Text)

12. Zika Virüsüne karşı in-siliko ilaç tasarımı

Kok M. A., TATAR G., Taşkın Tok T.
3.Uluslararası Avrasya Multidisipliner Çalışmalar Kongresi, Gaziantep, Turkey, 4 - 07 April 2019, pp.304-311, (Full Text) Sustainable Development

13. Üç boyutlu DNA Aptamer Temelli Biyosensönler ile Endrokin bozucu kimyasallarin tespit edilmesi

BAYIL İ., TATAR G., TASKIN TOK T.
3.Uluslararası Avrasya Multidisipliner Çalışmalar Kongresi, Gaziantep, Turkey, 4 - 07 April 2019, pp.334-339, (Full Text)

14. Recent Developments in eEF2 Kinase Inhibitors

AY M., CÖMERT ÖNDER F., KANDEMİR H., TAŞKIN TOK T., BELLUR ATİCİ E., TATAR G., et al.
International Conference on PharmaScience Research and Development (Pharma RD 2019), Paris, France, 4 - 06 March 2019, pp.25-26, (Summary Text)

15. Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: Structure Based Docking,ADMET and Molecular Dynamics Simulation

TATAR G.
Proteinlerin Yapısı ve Etkileşimleri konulu Biyofizik Yaz Okulu, 29 - 30 August 2018, (Full Text)

16. Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor

TATAR G., TASKIN TOK T., HASSAN Y., MOHAMMED A. D.
1. Uluslararası Kanser ve İyon Kanalları Kongresi, Şanlıurfa, Turkey, 21 - 23 September 2017, pp.132, (Full Text)

17. Molecular Docking Study of Rho-Kinase (ROCK) inhibitors

BAYEL SECINTI B., TATAR G., TASKIN TOK T.
Innovation in Medicine Summit-3, Gaziantep, Turkey, 11 - 13 May 2017, pp.84, (Full Text)

18. Evaluation of Docking Functions for ROCK2-Ligands Docking

YILDIRIM M., TATAR G., TASKIN TOK T.
4th International BAU Drug Design Congress, Gaziantep, Turkey, 13 - 15 October 2016, pp.230, (Full Text)

19. Investigation of mutation on the molecular functions of ROCK2 (Rho-kinase2) protein with molecular modeling techniques

TATAR G.
EMBO Integrative modeling of biomolecular interactions practical course, Barselona, Spain, 4 - 09 July 2016, pp.35, (Full Text)

20. Investigation of mutation on the molecular functions of ROCK2 protein with molecular modeling techniques

TATAR G., TAŞKIN TOK T.
Summer school on Molecular Modeling 4, Sardinia, Italy, 6 - 10 June 2016, (Summary Text)

21. Computer-assisted Drug Design and Development

TASKIN TOK T., TATAR G.
Innovation in Medicine Summit-2, Gaziantep, Turkey, 05 May 2016 - 07 May 2017, pp.79, (Full Text)

22. Voltaj Kapılı Potasyum Kanal Proteinin Kv1 2 Homoloji Modellenmesi ve HsTx1 Toksini ile Etkileşim Mekanizmaların Docking Yöntemiyle Aydınlatılması

YILMAZ K., TATAR G., TAŞKIN TOK T.
27. Ulusal Kimya Kongresi, Turkey, 23 - 28 August 2015, (Summary Text)

23. Elucidation of Interaction Mechanism of Coronavirus protein with Molecular Docking

TATAR G., TASKIN TOK T.
Modeling of Biomolecular Systems Interactions, Dynamics and Allostery: Bridging Experiments and Computations, İstanbul, Turkey, 10 - 14 September 2014, pp.137, (Full Text) Sustainable Development

24. Homology modeling of Coronavirus (CoV) structural proteins and its interaction mechanism analysis

TATAR G., TAŞKIN TOK T.
2. İlaç Kimyası, Üretim, Teknoloji ve Standardizasyon Kongresi, Turkey, 21 - 23 March 2014, (Summary Text) Sustainable Development
Books 4

1. Diş hekimliğine yönelik antimikrobiyal ajanların geliştirilmesinde bilgisayar destekli ilaç tasarımının rolü

Alemdağ İ. N., Tatar Yılmaz G., Tüzüner T.
in: Ağız Mikrobiyolojisi, Ali Rıza Alpöz, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.41-44, 2023 Creative Commons License

2. Bilgisayar destekli ilaç tasarımı

Tatar Yılmaz G.
in: Protein yapısı, mühendisliği, etkileşimleri, dinamiği ve ilaç tasarımındaki yeri, Saliha Ece Acuner, Editor, Nobel Tıp Kitapevi, Ankara, pp.291-307, 2021

3. BİLGİSAYAR DESTEKLİ İLAÇ TASARIMI

TATAR YILMAZ G.
in: PROTEİN: YAPISI, MÜHENDİSLİĞİ, ETKİLEŞİMLERİ, DİNAMİĞİ VE İLAÇ TASARIMINDAKİ YERİ, Saliha Ece ACUNER, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.291-307, 2021

4. BİLGİSAYAR DESTEKLİ İLAÇ TASARIMI

TATAR YILMAZ G.
in: PROTEİN: YAPISI, MÜHENDİSLİĞİ, ETKİLEŞİMLERİ, DİNAMİĞİ VE İLAÇ TASARIMINDAKİ YERİ, Acuner Ece Saliha, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.291-307, 2021
Metrics

Publication

73

Publication (WoS)

41

Publication (Scopus)

41

Citation (WoS)

448

H-Index (WoS)

13

Citation (Scopus)

463

H-Index (Scopus)

14

Citation (Scholar)

689

H-Index (Scholar)

14

Citation (TrDizin)

4

H-Index (TrDizin)

1

Citation (Sobiad)

14

H-Index (Sobiad)

2

Citation (Sum Other)

5

Total Citation Count

471

Project

15

Intellectual Property

1

Thesis Advisory

6

Open Access

8
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 4: GOAL 4: QUALITY EDUCATION
SDG 8: GOAL 8: DECENT WORK AND ECONOMIC GROWTH
SDG 9: GOAL 9: INDUSTRIAL INNOVATION AND INFRASTRUCTURE
SDG 17: GOAL 17: PARTNERSHIPS FOR THE GOALS